This study not only identified the oncogenic function of HIF1A-AS2 in CRC, but also provided new therapeutic targets based on the HIF1A-AS2/miR-129-5p/DNMT3A ceRNA network. This evidence concerns the gene HIF1A and colorectal carcinoma.